ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
-13.63%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$179M
AUM Growth
-$31.4M
Cap. Flow
+$5.98M
Cap. Flow %
3.35%
Top 10 Hldgs %
60.48%
Holding
53
New
12
Increased
12
Reduced
10
Closed
9

Top Buys

1
RCUS icon
Arcus Biosciences
RCUS
$4.24M
2
DTIL icon
Precision BioSciences
DTIL
$3.28M
3
UTHR icon
United Therapeutics
UTHR
$3.06M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.82M
5
RZLT icon
Rezolute
RZLT
$2.08M

Top Sells

1
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
$5.52M
2
AVDL
Avadel Pharmaceuticals
AVDL
$3.96M
3
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
$2.47M
4
ATHA icon
Athira Pharma
ATHA
$1.89M
5
MRUS icon
Merus
MRUS
$1.85M

Sector Composition

1 Healthcare 89.23%
2 Financials 7.77%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PMVP icon
26
PMV Pharmaceuticals
PMVP
$77.4M
$2.17M 1.21%
152,500
+17,000
+13% +$242K
RZLT icon
27
Rezolute
RZLT
$696M
$2.08M 1.16%
+645,136
New +$2.08M
IOVA icon
28
Iovance Biotherapeutics
IOVA
$901M
$1.7M 0.95%
154,356
+35,500
+30% +$392K
PYXS icon
29
Pyxis Oncology
PYXS
$118M
$1.54M 0.86%
645,149
+445,149
+223% +$1.06M
VTYX icon
30
Ventyx Biosciences
VTYX
$180M
$1.49M 0.83%
122,000
+51,123
+72% +$625K
ENTA icon
31
Enanta Pharmaceuticals
ENTA
$189M
$1.3M 0.72%
27,500
+25,200
+1,096% +$1.19M
ITOS
32
DELISTED
iTeos Therapeutics
ITOS
$1.28M 0.71%
+62,000
New +$1.28M
ACAD icon
33
Acadia Pharmaceuticals
ACAD
$4.26B
$1.01M 0.56%
+71,500
New +$1.01M
FULC icon
34
Fulcrum Therapeutics
FULC
$414M
$980K 0.55%
200,000
– –
GOSS icon
35
Gossamer Bio
GOSS
$668M
$268K 0.15%
+32,000
New +$268K
VSTM icon
36
Verastem
VSTM
$663M
$232K 0.13%
16,667
-66,412
-80% -$924K
SWTX
37
DELISTED
SpringWorks Therapeutics
SWTX
$123K 0.07%
+5,000
New +$123K
TRVI icon
38
Trevi Therapeutics
TRVI
$854M
$98K 0.05%
+35,000
New +$98K
OCUL icon
39
Ocular Therapeutix
OCUL
$2.37B
$53K 0.03%
+13,171
New +$53K
NUVB.WS icon
40
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
$25K 0.01%
+90,832
New +$25K
ACIU icon
41
AC Immune
ACIU
$229M
– –
0
– –
ATHA icon
42
Athira Pharma
ATHA
$15.4M
– –
-140,030
Closed -$1.89M
AVDL
43
Avadel Pharmaceuticals
AVDL
$1.53B
– –
-580,000
Closed -$3.96M
NUVB icon
44
Nuvation Bio
NUVB
$1.33B
– –
-90,832
Closed -$69K
SEEL
45
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
-77
Closed -$248K
IMGN
46
DELISTED
Immunogen Inc
IMGN
– –
-55,000
Closed -$262K
HARP
47
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-49,750
Closed -$2.47M
MTEM
48
DELISTED
Molecular Templates, Inc.
MTEM
– –
-20,475
Closed -$1.06M
DICE
49
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-37,500
Closed -$717K
JNCE
50
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-813,500
Closed -$5.52M
1
2